Tag: Quest Diagnostics
By the Numbers: Customer support
In this edition of "By the Numbers," we look at the numerical values that enable our Customer Support team to serve our customers effectively.
Opioid crisis persists during pandemic
The disruption of the SARS-CoV-2 coronavirus extends to all areas of life – including the opioid epidemic. Stress during an outbreak can include increased drug and alcohol use and impacts for those struggling with substance use disorders and addiction.
Alcohol use and the workplace
Alcohol testing can help employers make decisions to help keep their employees safe and can help determine whether an individual is impaired from alcohol.
Ask the experts: Is an oral fluid drug test safe?
During the novel coronavirus health crisis, many employers ask is if an oral fluid drug test is safe in the current circumstances. Under rigorous safety procedures, drug testing continues across the country.
Spread the message of workplace safety
June is National Safety Month. Take this opportunity to spread the word about the importance of workplace safety to help prevent injuries and fatalities.
Electronic breath alcohol test (eBAT) now available
With an expanding collection site network, electronic breath alcohol testing, or eBAT, from an industry leader is now a reality.
Webinar: COVID-19 and the Workplace
Scientists from Quest Diagnostics presented a webinar called, “Ask the experts: COVID-19 and the Workplace." Watch a recording on-demand.
Quest Diagnostics Employer Solutions welcomes Keith Ward
Keith Ward is the new leader of Quest Diagnostics Employer Solutions. We offer reliable workplace drug testing, an extensive collection site network, and personal service and support.
What you need to know about hair drug testing
Employers choose hair testing to help identify habitual and periodic drug users using its 90-day drug detection window. Get the facts.
International drugs: Growing marijuana users
Nearly 188 million people use marijuana globally, making it the most-used illicit substance according to the World Drug Report.
